Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $5.27 billion. The enterprise value is $4.69 billion.

Market Cap	5.27B
Enterprise Value	4.69B

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

XENE has 96.64 million shares outstanding. The number of shares has increased by 1.75% in one year.

Current Share Class	96.64M
Shares Outstanding	96.64M
Shares Change (YoY)	+1.75%
Shares Change (QoQ)	+1.11%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	82.95%
Float	89.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	702.66
Forward PS	n/a
PB Ratio	7.50
P/TBV Ratio	9.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	625.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.42, with a Debt / Equity ratio of 0.01.

Current Ratio	13.42
Quick Ratio	13.17
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.76% and return on invested capital (ROIC) is -34.45%.

Return on Equity (ROE)	-51.76%
Return on Assets (ROA)	-32.58%
Return on Invested Capital (ROIC)	-34.45%
Return on Capital Employed (ROCE)	-63.09%
Weighted Average Cost of Capital (WACC)	8.34%
Revenue Per Employee	$20,270
Profits Per Employee	-$934,892
Employee Count	370
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, XENE has paid $1.02 million in taxes.

Income Tax	1.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.95% in the last 52 weeks. The beta is 0.75, so XENE's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+44.95%
50-Day Moving Average	52.96
200-Day Moving Average	42.90
Relative Strength Index (RSI)	45.00
Average Volume (20 Days)	874,011

Short Selling Information

The latest short interest is 4.85 million, so 5.02% of the outstanding shares have been sold short.

Short Interest	4.85M
Short Previous Month	4.85M
Short % of Shares Out	5.02%
Short % of Float	5.40%
Short Ratio (days to cover)	4.13

Income Statement

In the last 12 months, XENE had revenue of $7.50 million and -$345.91 million in losses. Loss per share was -$4.36.

Revenue	7.50M
Gross Profit	-293.44M
Operating Income	-373.07M
Pretax Income	-344.89M
Net Income	-345.91M
EBITDA	-370.53M
EBIT	-373.07M
Loss Per Share	-$4.36

Full Income Statement

Balance Sheet

The company has $548.89 million in cash and $7.94 million in debt, giving a net cash position of $578.09 million or $5.98 per share.

Cash & Cash Equivalents	548.89M
Total Debt	7.94M
Net Cash	578.09M
Net Cash Per Share	$5.98
Equity (Book Value)	581.76M
Book Value Per Share	7.27
Working Capital	518.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$279.12 million and capital expenditures -$799,000, giving a free cash flow of -$279.92 million.

Operating Cash Flow	-279.12M
Capital Expenditures	-799,000
Depreciation & Amortization	2.54M
Net Borrowing	n/a
Free Cash Flow	-279.92M
FCF Per Share	-$2.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-4,974.27%
Pretax Margin	-4,598.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.75%
Shareholder Yield	-1.75%
Earnings Yield	-6.56%
FCF Yield	-5.31%

Analyst Forecast

The average price target for XENE is $68.55, which is 25.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$68.55
Price Target Difference	25.71%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	107.88%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XENE has an Altman Z-Score of 29.45 and a Piotroski F-Score of 1.

Altman Z-Score	29.45
Piotroski F-Score	1